Allscripts Healthcare Solutions Stock Rating Reaffirmed by Credit Suisse (MDRX)
Allscripts Healthcare Solutions (NASDAQ:MDRX)‘s stock had its “outperform” rating reaffirmed by Credit Suisse in a research note issued on Tuesday. They currently have a $18.00 price target on the stock, down from their previous price target of $19.00. Credit Suisse’s target price would indicate a potential upside of 24.91% from the stock’s previous close.
Shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) traded down 0.21% on Tuesday, hitting $14.38. 105,852 shares of the company’s stock traded hands. Allscripts Healthcare Solutions has a one year low of $13.72 and a one year high of $19.68. The stock’s 50-day moving average is $15.81 and its 200-day moving average is $16.3. The company’s market cap is $2.591 billion.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.09 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.09. The company had revenue of $351.30 million for the quarter, compared to the consensus estimate of $353.12 million. During the same quarter last year, the company posted $0.13 earnings per share. Allscripts Healthcare Solutions’s revenue was up 1.9% compared to the same quarter last year. On average, analysts predict that Allscripts Healthcare Solutions will post $0.38 earnings per share for the current fiscal year.
Several other analysts have also recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Allscripts Healthcare Solutions in a research note on Monday, August 11th. They now have a $16.00 price target on the stock. Separately, analysts at Raymond James reiterated an “outperform” rating on shares of Allscripts Healthcare Solutions in a research note on Friday, August 8th. They now have a $18.00 price target on the stock, down previously from $18.50. Finally, analysts at Jefferies Group upgraded shares of Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating in a research note on Wednesday, July 23rd. They now have a $21.00 price target on the stock, up previously from $15.00. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $18.50.
Allscripts Healthcare Solutions, Inc (NASDAQ:MDRX) is a provider of clinical, financial, connectivity and information solutions and related professional services to hospitals, physicians and post-acute organizations.
Receive News & Ratings for Allscripts Healthcare Solutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.